TherapeuticsMD, Inc. Total Liabilities and Equity
TherapeuticsMD, Inc. (TXMD) had Total Liabilities and Equity of $37.53 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-11
- 2026-06-30: Liabilities and Equity $37.53M.
- 2026-03-31: Liabilities and Equity $37.58M.
- 2025-12-31: Liabilities and Equity $37.66M.
- 2025-09-30: Liabilities and Equity $38.67M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $37.53M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $37.58M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $37.66M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $38.67M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $38.50M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $38.24M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $38.82M 10-K/A · filed 2026-04-01 | |
| 2024-06-30 | $40.13M 10-Q · filed 2024-08-12 | |
| 2023-12-31 | $43.31M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $50.49M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $53.69M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $59.60M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $90.46M 10-K · filed 2024-03-29 | |
| 2022-09-30 | $133.91M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $146.20M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $133.38M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $169.47M 10-K · filed 2023-04-07 | |
| 2021-09-30 | $209.63M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $210.60M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $239.31M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $181.61M 10-K · filed 2022-03-23 | $181.61M 10-K · filed 2021-03-04 |
| 2020-09-30 | $177.29M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $205.54M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $268.64M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $265.99M 10-K · filed 2021-03-04 | |
| 2019-09-30 | $249.96M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $246.55M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $181.89M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $211.98M 10-K · filed 2020-02-24 | |
| 2018-09-30 | $236.75M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $171.90M 10-Q · filed 2018-07-30 | |
| 2018-03-31 | $122.96M 10-Q · filed 2018-05-07 | |
| 2017-12-31 | $143.23M 10-K · filed 2019-02-27 | |
| 2017-09-30 | $160.36M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $106.88M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $124.42M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $142.47M 10-K · filed 2018-02-23 | |
| 2016-09-30 | $158.82M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $176.59M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $192.97M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $73.73M 10-K · filed 2017-02-28 | |
| 2015-09-30 | $90.46M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $75.68M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $99.48M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $59.08M 10-K · filed 2016-02-26 | |
| 2014-09-30 | $74.61M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $44.43M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $53.57M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $62.02M 10-K · filed 2015-03-12 | |
| 2013-09-30 | $68.48M 10-Q · filed 2013-11-05 | |
| 2013-06-30 | $43.07M 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $44.19M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $5.93M 10-K · filed 2014-03-05 | $5.82M 10-K · filed 2013-03-12 |
| 2012-09-30 | $3.51M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $4.88M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $1.49M 10-Q · filed 2012-05-11 | |
| 2011-12-31 | $1.44M 10-K · filed 2013-03-12 | |
| 2011-09-30 | $7.34K 10-Q · filed 2011-11-07 | |
| 2011-06-30 | $5.45K 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $467.42K 10-Q · filed 2011-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |